SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christine Garcia, C. Bethan Powell, A Comprehensive Approach to the Identification and Management of the BRCA Patient, Obstetrical & Gynecological Survey, 2015, 70, 2, 131

    CrossRef

  2. 2
    C. Bethan Powell, Clinical management of patients at inherited risk for gynecologic cancer, Current Opinion in Obstetrics and Gynecology, 2015, 27, 1, 14

    CrossRef

  3. 3
    Thereasa A. Rich, Ashley H. Woodson, Jennifer Litton, Banu Arun, Hereditary breast cancer syndromes and genetic testing, Journal of Surgical Oncology, 2015, 111, 1
  4. 4
    Adele Wong, Joanne Ngeow, Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?, BioMed Research International, 2015, 2015, 1

    CrossRef

  5. 5
    Lisa R. Susswein, Megan L. Marshall, Rachel Nusbaum, Kristen J. Vogel Postula, Scott M. Weissman, Lauren Yackowski, Erica M. Vaccari, Jeffrey Bissonnette, Jessica K. Booker, M. Laura Cremona, Federica Gibellini, Patricia D. Murphy, Daniel E. Pineda-Alvarez, Guido D. Pollevick, Zhixiong Xu, Gabi Richard, Sherri Bale, Rachel T. Klein, Kathleen S. Hruska, Wendy K. Chung, Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing, Genetics in Medicine, 2015,

    CrossRef

  6. 6
    Kara N. Maxwell, Bradley Wubbenhorst, Kurt D’Andrea, Bradley Garman, Jessica M. Long, Jacquelyn Powers, Katherine Rathbun, Jill E. Stopfer, Jiajun Zhu, Angela R. Bradbury, Michael S. Simon, Angela DeMichele, Susan M. Domchek, Katherine L. Nathanson, Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer, Genetics in Medicine, 2015, 17, 8, 630

    CrossRef

  7. 7
    Brian T. Wilson, Heather J. Cordell, Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy, Journal of Gynecologic Oncology, 2015, 26, 4, 249

    CrossRef

  8. 8
    Burak Yılmaz, Catherine Moroski-Erkul, Omer Hatipoglu, Esra Gunduz, Debmalya Barh, Mehmet Gunduz, Noninvasive Molecular Markers in Gynecologic Cancers, 2015,

    CrossRef

  9. 9
    Gerasimos Tzortzatos, Ofra Wersäll, Kristina Danielsson, Annika Lindblom, Emma Tham, Miriam Mints, Familial cancer among consecutive uterine cancer patients in Sweden, Hereditary Cancer in Clinical Practice, 2014, 12, 1, 14

    CrossRef

  10. 10
    Ayelet Shai, Yakir Segev, Steven A. Narod, Genetics of endometrial cancer, Familial Cancer, 2014, 13, 3, 499

    CrossRef

  11. 11
    Iryna Vyarvelska, Barry Rosen, Steven A. Narod, Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?, Gynecologic Oncology, 2014, 134, 2, 219

    CrossRef

  12. 12
    Caitlin B. Mauer, Sara M. Pirzadeh-Miller, Linda D. Robinson, David M. Euhus, The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience, Genetics in Medicine, 2014, 16, 5, 407

    CrossRef

  13. 13
    Michael O. Dorschner, Laura M. Amendola, Emily H. Turner, Peggy D. Robertson, Brian H. Shirts, Carlos J. Gallego, Robin L. Bennett, Kelly L. Jones, Mari J. Tokita, James T. Bennett, Jerry H. Kim, Elisabeth A. Rosenthal, Daniel S. Kim, Holly K. Tabor, Michael J. Bamshad, Arno G. Motulsky, C. Ronald Scott, Colin C. Pritchard, Tom Walsh, Wylie Burke, Wendy H. Raskind, Peter Byers, Fuki M. Hisama, Deborah A. Nickerson, Gail P. Jarvik, Actionable, Pathogenic Incidental Findings in 1,000 Participants’ Exomes, The American Journal of Human Genetics, 2013, 93, 4, 631

    CrossRef

  14. 14
    Amanda Nickles Fader, Alessandro D. Santin, Paola A. Gehrig, Early stage uterine serous carcinoma: Management updates and genomic advances, Gynecologic Oncology, 2013, 129, 1, 244

    CrossRef

  15. 15
    Louise A. Brinton, Ashley S. Felix, D. Scott McMeekin, William T. Creasman, Mark E. Sherman, David Mutch, David E. Cohn, Joan L. Walker, Richard G. Moore, Levi S. Downs, Robert A. Soslow, Richard Zaino, Etiologic heterogeneity in endometrial cancer: Evidence from a Gynecologic Oncology Group trial, Gynecologic Oncology, 2013, 129, 2, 277

    CrossRef

  16. 16
    Dana Meaney-Delman, Cecelia A. Bellcross, Hereditary Breast/Ovarian Cancer Syndrome, Obstetrics and Gynecology Clinics of North America, 2013, 40, 3, 475

    CrossRef

  17. 17
    Oluwole Fadare, Is there an association between type II endometrial carcinomas and breast cancers? A critical appraisal, Women's Health, 2013, 9, 4, 315

    CrossRef

  18. 18
    Gregg S. Nelson, Aaron Pink, Sandra Lee, Guangming Han, Don Morris, Travis Ogilvie, Máire A. Duggan, Martin Köbel, MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome, Gynecologic Oncology, 2013, 131, 2, 309

    CrossRef

  19. 19
    Yakir Segev, Javaid Iqbal, Jan Lubinski, Jacek Gronwald, Henry T. Lynch, Pal Moller, Parviz Ghadirian, Barry Rosen, Nadine Tung, Charmaine Kim-Sing, William D. Foulkes, Susan L. Neuhausen, Leigha Senter, Christian F. Singer, Beth Karlan, Sun Ping, Steven A. Narod, The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study, Gynecologic Oncology, 2013, 130, 1, 127

    CrossRef

  20. 20
    Stephanie Ricci, Amanda Nickles Fader, Treatment of uterine papillary serous carcinoma, Expert Opinion on Orphan Drugs, 2013, 1, 10, 819

    CrossRef

  21. 21
    Amanda Ramos, Amanda Nickles Fader, Updates on the Management of Uterine Serous Carcinoma,